Guangzhou Xiangxue Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the board of directors guarantee that the content of the information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
I. Situation of Extension of Pre-Reorganization Period
On February 24, 2026, the Company received the Decision No. (2025) Yue 01 Po Shen 54-3 from the Guangzhou Intermediate People's Court (hereinafter referred to as "Guangzhou Intermediate Court"). The main content is as follows: After examination, the court agrees to extend the Company's pre-reorganization period to April 11, 2026.